Narix Pharmaceuticals Private Limited

Cytomel (Liothyronine) Tablet Active T3 Thyroid Hormone for Hypothyroidism & Myxedema Coma Narix Pharmaceuticals Narix Pharmaceuticals manufactures Liothyronine (T3) Tablets, the active thyroid hormone � faster acting than levothyroxine (T4) with direct T3 activity, used for myxedema coma, T4-resistant hypothyroidism, and TSH suppression in thyroid cancer surveillance. Key Therapeutic Uses: � Myxedema coma � rapid T3 replacement (IV) � T4-to-T3 conversion impairment � direct T3 replacement � Hypothyroidism � combination T3+T4 therapy � TSH suppression in thyroid cancer surveillance � Thyroid suppression tests Available Strengths: 5 mcg 25 mcg 50 mcg Product Highlights: � Fastest acting thyroid hormone � direct T3 � WHO-GMP, DCGI approved � Available as tablets and injectable � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #LiothyronineTablet #CytomelGeneric #TertroxinGeneric #T3ThyroidHormone #HypothyroidismTablet #MyxedemaComa #LiothyronineManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Tagrisso (Osimertinib) Tablet Third-Generation EGFR TKI for T790M Resistant & First-Line NSCLC Narix Pharmaceuticals Narix Pharmaceuticals supplies Osimertinib Tablets, the third-generation irreversible EGFR TKI � the current standard-of-care first-line EGFR-mutant NSCLC treatment and the only EGFR TKI active against the T790M resistance mutation from prior TKIs. Key Therapeutic Uses: � EGFR T790M-mutated NSCLC � after first/second-gen TKI resistance � First-line EGFR-mutated NSCLC (FLAURA trial � superior OS vs gefitinib/erlotinib) � CNS metastases in EGFR-mutant NSCLC � CNS penetration � Adjuvant post-resection EGFR-mutant NSCLC Available Strengths: 40 mg 80 mg Product Highlights: � Current first-line standard for EGFR-mutant NSCLC � Active against T790M resistance � overcomes first/second-gen failure � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #OsimertinibTablet #TagrissoGeneric #OsicentGeneric #ThirdGenEGFRTKI #T790MResistance #NSCLCTablet #OsimertinibManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Desyrel (Trazodone) Tablet Serotonin Antagonist & Reuptake Inhibitor for Depression & Insomnia Narix Pharmaceuticals Narix Pharmaceuticals manufactures Trazodone Tablets, a SARI (Serotonin Antagonist and Reuptake Inhibitor) with dual benefit � antidepressant action and sleep promotion � making it the preferred antidepressant when sedation is therapeutically desirable. Key Therapeutic Uses: � Major depressive disorder with insomnia � Primary insomnia � low-dose off-label (highly prevalent) � Anxiety disorder with comorbid insomnia � Fibromyalgia and chronic pain-related sleep disturbance � SSRI augmentation for sleep Available Strengths: 50 mg 100 mg 150 mg 300 mg Product Highlights: � Non-habit-forming sleep aid � preferred over benzodiazepines � No anticholinergic side effects � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #TrazodoneTablet #DesyrelGeneric #SARIAntidepressant #InsomniaTablet #DepressionMedicine #TrazodoneManufacturer #SleepMedicine #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

BuSpar (Buspirone) Tablet Non-Habit-Forming Anxiolytic for GAD Narix Pharmaceuticals Narix Pharmaceuticals manufactures Buspirone Tablets, a partial 5-HT1A agonist anxiolytic treating GAD without dependence, sedation, or cognitive impairment associated with benzodiazepines � the only non-BZD, non-sedating anxiolytic approved for long-term use. Key Therapeutic Uses: � Generalized anxiety disorder (GAD) � first-line non-BZD � Patients transitioning off benzodiazepines � Anxiety with depression (SSRI add-on) � Elderly patients where BZD is contraindicated � Augmentation in treatment-resistant depression Available Strengths: 5 mg 10 mg 15 mg 30 mg Product Highlights: � No dependence, no sedation, no withdrawal � Safe for elderly patients and long-term use � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #BuspironeTablet #BuSparGeneric #AnxiolyticTablet #GADMedicine #NonBenzodiazepine #AnxietyTablet #BuspironeManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Aciphex (Rabeprazole) Tablet Fast-Acting PPI with Low CYP2C19 Dependence Narix Pharmaceuticals Narix Pharmaceuticals manufactures Rabeprazole Tablets, a PPI with the fastest onset of action and lowest dependence on CYP2C19 genetic polymorphism � providing consistent acid suppression across all patient populations regardless of metabolizer status. Key Therapeutic Uses: � GERD and erosive esophagitis � rapid symptom relief � H. pylori eradication � consistent across CYP2C19 genotypes � Peptic ulcer disease � gastric and duodenal � NSAID-induced ulcer prevention � Hypersecretory conditions � Zollinger-Ellison Available Strengths: 10 mg 20 mg Product Highlights: � Fastest acting PPI � quickest symptom relief � Least CYP2C19-dependent � consistent for all patients � WHO-GMP, DCGI approved � Very high prescription volume in India � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #RabeprazoleTablet #AciphexGeneric #RabletGeneric #ProtonPumpInhibitor #GERDTablet #FastActingPPI #RabeprazoleManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine #H2Eradication

Tofranil (Imipramine) Tablet First Antidepressant for Depression, Enuresis & Panic Disorder Narix Pharmaceuticals Narix Pharmaceuticals manufactures Imipramine Tablets, the prototype TCA with broad efficacy across depression, panic disorder, childhood enuresis, and neuropathic pain. Key Therapeutic Uses: � Major depressive disorder (MDD) � historical gold standard � Childhood nocturnal enuresis � first-line pharmacotherapy � Panic disorder � highly effective � Neuropathic pain � established evidence � ADHD in children (off-label) Available Strengths: 10 mg 25 mg 50 mg 75 mg Product Highlights: � First antidepressant � 60+ year clinical history � WHO EML listed for enuresis � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #ImipramineTablet #TofranilGeneric #TricyclicAntidepressant #EnuresisTablet #PanicDisorder #ImipramineManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Stelazine (Trifluoperazine) Tablet High-Potency Phenothiazine for Chronic Schizophrenia Narix Pharmaceuticals Narix Pharmaceuticals manufactures Trifluoperazine Tablets, a high-potency first-generation phenothiazine antipsychotic for chronic schizophrenia and short-term anxiety augmentation in developing market psychiatry. Key Therapeutic Uses: � Chronic schizophrenia � maintenance therapy � Non-psychotic anxiety � short-term adjunct (second-line) � Refractory nausea and vomiting � Behavioral disturbances in dementia Available Strengths: 1 mg 2 mg 5 mg 10 mg Product Highlights: � High-potency phenothiazine � cost-effective � WHO-GMP, DCGI approved � Widely used in developing markets � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #TrifluoperazineTablet #StelazineGeneric #PhenothiazineAntipsychotic #ChronicSchizophrenia #TypicalAntipsychotic #TrifluoperazineManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Ibrance (Palbociclib) Capsule First-in-Class CDK4/6 Inhibitor for HR+/HER2- Breast Cancer Narix Pharmaceuticals Narix Pharmaceuticals supplies Palbociclib Capsules, the first CDK4/6 inhibitor approved � transforming HR+/HER2- metastatic breast cancer treatment by adding 10+ months of progression-free survival when combined with letrozole or fulvestrant. Key Therapeutic Uses: � HR+/HER2- metastatic breast cancer � first-line with aromatase inhibitor � HR+/HER2- metastatic breast cancer � second-line with fulvestrant � Premenopausal HR+ breast cancer � with LHRH agonist Available Strengths: 75 mg 100 mg 125 mg Product Highlights: � First-in-class CDK4/6 inhibitor � pioneer drug � 10+ month PFS improvement over endocrine therapy alone � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #PalbociclibCapsule #IbranceGeneric #PalbonixGeneric #CDK46Inhibitor #BreastCancerTablet #HRPositiveBreastCancer #PalbociclibManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Narcan (naloxone HCl) nasal spray is an emergency treatment designed to rapidly reverse known or suspected opioid overdoses. It works by blocking opioid effects to restore breathing. Emergency medical services should be called immediately, and the device can be used in accordance with instructions provided by professionals or on the product label. 

Artane (Trihexyphenidyl) Tablet Anticholinergic Antiparkinson Agent for Tremor & EPS Narix Pharmaceuticals Narix Pharmaceuticals manufactures Trihexyphenidyl Tablets, a central anticholinergic antiparkinsonian agent widely used for Parkinson's disease tremor dominant type and drug-induced extrapyramidal symptoms (EPS) from antipsychotics. Key Therapeutic Uses: � Parkinson's disease � tremor-dominant type � Drug-induced extrapyramidal symptoms (EPS) � antipsychotic-induced � Acute dystonia from antipsychotics � Dystonia and spasticity (off-label, movement disorders) Available Strengths: 2 mg 5 mg Product Highlights: � Most prescribed anticholinergic for EPS in India � Cost-effective Parkinson's tremor control � WHO-GMP, DCGI approved � Very high demand in psychiatric and neurological settings � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #TrihexyphenidylTablet #ArtaneGeneric #PacitaneGeneric #AnticholinergicTablet #EPSTablet #AntiparkinsonianTablet #TrihexyphenidylManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Zyban (Bupropion SR) Tablet FDA-Approved Non-Nicotine Smoking Cessation Aid Narix Pharmaceuticals Narix Pharmaceuticals manufactures Bupropion SR Tablets (Zyban formulation), the first non-nicotine FDA-approved smoking cessation medication � an NDRI that reduces nicotine craving and withdrawal symptoms by blocking nicotinic receptors and increasing dopamine/norepinephrine. Key Therapeutic Uses: � Smoking cessation � first-line non-nicotine pharmacotherapy � Nicotine dependence � reduces withdrawal symptoms � Dual-purpose use in depressed smokers � treats both � Smoking cessation in patients with cardiovascular disease Available Strengths: 150 mg SR Product Highlights: � First non-nicotine smoking cessation drug � FDA approved 1997 � Doubles quit rates vs placebo � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #BupropionSRTablet #ZybanGeneric #SmokingCessationTablet #NonNicotineQuitSmoking #NicotineDependence #BupropionManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine #DeAddiction

Nurokind (Methylcobalamin) Tablet Active Vitamin B12 for Peripheral Neuropathy & B12 Deficiency Narix Pharmaceuticals Narix Pharmaceuticals manufactures Methylcobalamin Tablets, the neurologically active form of Vitamin B12 � superior to cyanocobalamin for peripheral neuropathy due to direct incorporation into nerve tissue without hepatic conversion. Key Therapeutic Uses: � Peripheral neuropathy � diabetic, alcoholic, drug-induced � Vitamin B12 deficiency and megaloblastic anemia � Subacute combined degeneration of spinal cord � Neuropathic pain � synergy with gabapentin � Alzheimer's disease and cognitive decline (adjunct) Available Strengths: 500 mcg 1000 mcg 1500 mcg Product Highlights: � Neurologically active form � directly repairs nerve tissue � India's highest-volume B12 product (Nurokind brand) � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #MethylcobalaminTablet #NurokindGeneric #ActiveVitaminB12 #PeripheralNeuropathy #B12Deficiency #MethylcobalaminManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Trenbolone Acetate 100mg Injectable Fast-Acting Anabolic Steroid Formulation Narix Pharmaceuticals Narix Pharmaceuticals supplies Trenbolone Acetate 100mg/ml Injectable, a fast-acting anabolic steroid oil-based injectable for pharmaceutical manufacturing. Product Specifications: � Trenbolone Acetate: 100 mg/ml � Packaging: 1ml ampoule Grade: Pharmaceutical � Country of Origin: India Applications: Short-acting anabolic steroid injectable formulations Storage: Store below 25�C, away from direct light #TrenboloneAcetateInjection #FastActingAnabolicInjection #TrenboloneInjectableManufacturer #NarixPharmaceuticals #WHOGMPCertified

Boldenone Undecylenate 400mg Injectable High-Concentration Anabolic Steroid Narix Pharmaceuticals Narix Pharmaceuticals supplies Boldenone Undecylenate 400mg/ml Injectable, a high-concentration pharmaceutical-grade anabolic steroid injectable. Product Specifications: � Boldenone Undecylenate: 400 mg/ml Grade: Pharmaceutical � Country of Origin: India MOQ: 1 Box #BoldenoneUndecylenate400 #HighConcAnabolicInjectable #BoldenoneManufacturer #NarixPharmaceuticals

Mesteronum (Mesterolone 25mg) Tablet Pharmaceutical Androgen for Male Health Narix Pharmaceuticals Narix Pharmaceuticals supplies Mesteronum Mesterolone 25mg Tablets for male androgen deficiency and infertility management. Product Specifications: � Mesterolone: 25 mg Brand: Mesteronum Grade: Pharmaceutical Applications: Male infertility, androgen deficiency, hypogonadism management #MesteronumTablet #Mesterolone25mg #MaleAndrogen #NarixPharmaceuticals

Viraday (Efavirenz + Lamivudine + Tenofovir) Tablet TLE Triple ART Regimen for HIV-1 Narix Pharmaceuticals Narix Pharmaceuticals supplies Efavirenz + Lamivudine + Tenofovir (TLE) Fixed-Dose Combination Tablets � the most widely prescribed single-pill first-line HIV ART regimen globally under PEPFAR and WHO HIV programs, combining two NRTIs with one NNRTI. Key Therapeutic Uses: � HIV-1 infection � first-line ART (WHO recommended) � Treatment-naive adult HIV patients � National HIV programs � PEPFAR and WHO 90-90-90 target � HIV with concurrent TB treatment (efavirenz preferred) Available Strengths: EFV 600 mg + 3TC 300 mg + TDF 300 mg Product Highlights: � WHO-recommended first-line HIV regimen � Single daily pill � highest adherence in HIV care � WHO-GMP, DCGI approved � Widely exported to Sub-Saharan Africa and ASEAN � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #EFVTLETablet #ViradayGeneric #TLEFDCTablet #HIVMedicine #ARTTablet #FirstLineART #AntiretroviralTablet #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine #PEPFARMedicine

Testosterone Propionate 100mg Injectable Short-Acting TRT Narix Pharmaceuticals Narix Pharmaceuticals supplies Testosterone Propionate 100mg/ml Injectable, a short-acting testosterone ester for frequent-dosing testosterone replacement therapy. Product Specifications: � Testosterone Propionate: 100 mg/ml Form: Oil-based injectable � Grade: Pharmaceutical USP Country of Origin: India Applications: Short-acting TRT, eod testosterone protocols #TestosteronePropionate100 #ShortActingTRT #TestosteroneInjectableManufacturer #NarixPharmaceuticals

Testosterone Propionate 100mg Ampoule USP Grade Injectable Narix Pharmaceuticals Narix Pharmaceuticals supplies Testosterone Propionate 100mg/ml Ampoule in USP pharmaceutical grade. Product Specifications: � Testosterone Propionate: 100 mg/ml Presentation: Ampoule Grade: USP #TestosteronePropionateAmpoule #USPGradeTestosterone #TestosteroneManufacturer #NarixPharmaceuticals

Venclexta (Venetoclax) Tablet First-in-Class BCL-2 Inhibitor for CLL & AML Narix Pharmaceuticals Narix Pharmaceuticals supplies Venetoclax Tablets, the first-in-class BCL-2 (B-cell lymphoma 2) inhibitor that restores apoptosis in cancer cells overexpressing BCL-2 � transforming CLL and AML treatment with deep remissions and MRD-negativity. Key Therapeutic Uses: � Chronic lymphocytic leukemia (CLL) � with obinutuzumab or rituximab � Acute myeloid leukemia (AML) � with azacitidine in elderly/unfit patients � Relapsed/refractory CLL � monotherapy � Multiple myeloma � combination regimens (off-label, emerging) Available Strengths: 10 mg 50 mg 100 mg Product Highlights: � First-in-class BCL-2 inhibitor � Nobel mechanism � Achieves MRD-negative responses in CLL � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #VenetoclaxTablet #VenclextaGeneric #VenetnatGeneric #BCL2Inhibitor #CLLMedicine #AMLMedicine #VenetoclaxManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Mycobutin (Rifabutin) Capsule Rifamycin for TB in HIV & MAC Prophylaxis Narix Pharmaceuticals Narix Pharmaceuticals supplies Rifabutin Capsules, a rifamycin S antibiotic with lower enzyme induction than rifampicin � preferred over rifampicin in HIV/TB coinfection (less interaction with antiretrovirals) and used for MAC prophylaxis in advanced HIV. Key Therapeutic Uses: � TB treatment in HIV+ patients � less drug interaction than rifampicin � Mycobacterium avium complex (MAC) prophylaxis in HIV � MAC treatment � combination with clarithromycin and ethambutol � H. pylori eradication � rifabutin-based rescue therapy Available Strengths: 150 mg 300 mg Product Highlights: � Preferred rifamycin for HIV/TB coinfection � WHO-GMP, DCGI approved � Critical drug for TB-HIV programs � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #RifabutinCapsule #MycobutinGeneric #RifamycinAntibiotic #TBHIVCoinfection #MACProphylaxis #RifabutinManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Sintrom (Acenocoumarol) Tablet Short-Acting Oral Anticoagulant Narix Pharmaceuticals Narix Pharmaceuticals manufactures Acenocoumarol Tablets, a short-acting coumarin oral anticoagulant widely used across South Asia, Europe, and MENA. Its shorter half-life vs warfarin allows quicker INR adjustments. Key Therapeutic Uses: � Prevention and treatment of DVT and pulmonary embolism � Stroke prevention in atrial fibrillation � Mechanical heart valve anticoagulation � Post-orthopedic surgery thromboprophylaxis Available Strengths: 1 mg 2 mg 4 mg Product Highlights: � Shorter half-life than warfarin � quicker INR adjustment � WHO-GMP, DCGI approved � Preferred in India, South Asia, Middle East markets � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #AcenocoumarolTablet #SintromGeneric #OralAnticoagulant #VKATablet #AtrialFibrillationTablet #DVTTreatment #AcenocoumarolManufacturer #CardiacMedicine #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Symmetrel (Amantadine) Tablet Dopamine Releaser for Parkinson's Disease & Influenza Narix Pharmaceuticals Narix Pharmaceuticals manufactures Amantadine Tablets, a dopamine-releasing antiparkinsonian agent with additional antiviral (influenza A) and antidyskinetic properties � the only oral drug proven to reduce levodopa-induced dyskinesia in Parkinson's disease. Key Therapeutic Uses: � Parkinson's disease � early monotherapy and dyskinesia control � Levodopa-induced dyskinesia � proven reduction � Influenza A prevention and treatment (historically) � Drug-induced extrapyramidal symptoms (EPS) � Fatigue in multiple sclerosis (off-label) Available Strengths: 100 mg Product Highlights: � Only oral drug for levodopa-induced dyskinesia � WHO-GMP, DCGI approved � Antiviral + antiparkinsonian dual action � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #AmantadineTablet #SymmetrelGeneric #AntiparkinsonianTablet #LevodopaInducedDyskinesia #ParkinsonsMedicine #AmantadineManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine #DopamineReleaser

Sinemet (Levodopa + Carbidopa) Tablet Gold Standard Parkinson's Disease Therapy Narix Pharmaceuticals Narix Pharmaceuticals manufactures Levodopa + Carbidopa FDC Tablets, the gold standard for Parkinson's disease. Carbidopa inhibits peripheral dopa decarboxylase � allowing more levodopa to cross the blood-brain barrier while reducing nausea and other peripheral side effects. Key Therapeutic Uses: � Parkinson's disease � all stages (gold standard motor therapy) � Rigidity, tremor, bradykinesia � symptomatic relief � Post-encephalitic and idiopathic parkinsonism � Restless legs syndrome � augmentation refractory to agonists Available Strengths: Levodopa 100 mg + Carbidopa 25 mg 250/25 mg 100/10 mg CR Product Highlights: � Gold standard Parkinson's pharmacotherapy � Standard-release and CR formulations � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #LevodopaCardbidopaTablet #SinemetGeneric #SyndopaGeneric #ParkinsonsDiseaseMedicine #AntiparkinsonianTablet #LevodopaManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Stugeron (Cinnarizine) Tablet Calcium Channel Blocker for Vertigo, Motion Sickness & Peripheral Vascular Disease Narix Pharmaceuticals Narix Pharmaceuticals manufactures Cinnarizine Tablets, a calcium channel blocker with antihistamine activity used for vertigo, motion sickness, and peripheral vascular disorders � one of India's highest-volume vertigo medications. Key Therapeutic Uses: � Vertigo � Meniere's disease, labyrinthitis, positional vertigo � Motion sickness � prevention and treatment � Peripheral vascular disease and cerebrovascular insufficiency � Vestibular migraine prophylaxis � Tinnitus of vascular origin Available Strengths: 25 mg 75 mg (also with Dimenhydrinate FDC) Product Highlights: � Very high prescription volume in India � Available standalone and Dimenhydrinate FDC � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #CinnarizineTablet #StugeronGeneric #AntivertigoTablet #VertigoMedicine #MotionSicknessTablet #CinnarizineManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Solian (Amisulpride) Tablet Benzamide Antipsychotic for Schizophrenia & Negative Symptoms Narix Pharmaceuticals Narix Pharmaceuticals manufactures Amisulpride Tablets, a substituted benzamide with dose-dependent effects � low doses improve negative symptoms (presynaptic D2 block), high doses treat positive symptoms (postsynaptic D2 block). Key Therapeutic Uses: � Schizophrenia � positive and negative symptoms � Negative symptom-predominant schizophrenia � Dysthymia/persistent depressive disorder (low dose) � Postoperative nausea and vomiting (off-label) Available Strengths: 50 mg 100 mg 200 mg 400 mg Product Highlights: � Dose-dependent dual mechanism � unique pharmacology � Effective for negative symptoms � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #AmisulprideTablet #SolianGeneric #BenzamideAntipsychotic #NegativeSymptomSchizophrenia #SchizophreniaTablet #AmisulprideManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Boniva (Ibandronate) Tablet Once-Monthly Bisphosphonate for Postmenopausal Osteoporosis Narix Pharmaceuticals Narix Pharmaceuticals manufactures Ibandronate Tablets, a potent bisphosphonate uniquely available as a once-monthly oral tablet � providing the highest convenience among oral bisphosphonates for postmenopausal osteoporosis. Key Therapeutic Uses: � Postmenopausal osteoporosis � once-monthly tablet � Prevention of vertebral fractures � Bone metastases from breast cancer (IV formulation) � Hypercalcemia of malignancy Available Strengths: 50 mg (daily) 150 mg (monthly) Product Highlights: � Only once-monthly oral bisphosphonate � highest convenience � WHO-GMP, DCGI approved � IV formulation also available � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #IbandronateTablet #BonivaGeneric #BandroneGeneric #MonthlyBisphosphonate #OsteoporosisTablet #VertebralFractureTablet #IbandronateManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Actonel (Risedronate) Tablet Potent Bisphosphonate for Osteoporosis with Better GI Tolerance Narix Pharmaceuticals Narix Pharmaceuticals manufactures Risedronate Tablets, a potent nitrogen-containing bisphosphonate with better upper GI tolerability than alendronate � available in daily, weekly, and monthly dosing regimens for osteoporosis management. Key Therapeutic Uses: � Postmenopausal osteoporosis � daily/weekly/monthly options � Male osteoporosis and glucocorticoid-induced osteoporosis � Paget's disease of bone � Prevention of hip and vertebral fractures Available Strengths: 5 mg (daily) 35 mg (weekly) 75 mg (2 days/month) 150 mg (monthly) Product Highlights: � Multiple dosing regimens � daily, weekly, monthly � Better GI tolerability vs alendronate � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #RisedronateTablet #ActonelGeneric #BisphosphonateTablet #OsteoporosisTablet #BoneFracturePreventions #RisedronateManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Prevymis (Letermovir) Tablet First-in-Class CMV Terminase Inhibitor for Transplant Prophylaxis Narix Pharmaceuticals Narix Pharmaceuticals manufactures Letermovir Tablets, the first-in-class cytomegalovirus (CMV) terminase complex inhibitor � with a completely novel mechanism of action distinct from ganciclovir � used for CMV prophylaxis in adult CMV-seropositive allogeneic hematopoietic stem cell transplant recipients. Key Therapeutic Uses: � CMV prophylaxis in allogeneic HSCT recipients � FDA-approved � CMV-seropositive donor/recipient transplant programs � Patients intolerant to ganciclovir/valganciclovir � CMV prevention in kidney and solid organ transplant (off-label) Available Strengths: 240 mg 480 mg Product Highlights: � First-in-class CMV terminase inhibitor � novel mechanism � No myelosuppression � unlike ganciclovir � WHO-GMP, DCGI approved � Critical transplant medicine � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #LetermovirTablet #PrevymisGeneric #CMVTerminaseInhibitor #CMVProphylaxis #TransplantMedicine #LetermovirManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine #HSCTProphylaxis

Zantac (Ranitidine) Tablet Classic H2 Blocker for GERD, Ulcers & Acid Suppression Narix Pharmaceuticals Narix Pharmaceuticals manufactures Ranitidine Tablets, a classic H2 receptor antagonist with proven efficacy for peptic ulcer disease, GERD, and gastritis � widely used across developing markets for its affordability, rapid onset, and established safety profile. Key Therapeutic Uses: � Peptic ulcer disease � gastric and duodenal � GERD and acid reflux � acute management � Stress ulcer prophylaxis in ICU � Zollinger-Ellison syndrome � Dyspepsia and heartburn � symptomatic relief � Pre-anesthetic medication (aspiration prophylaxis) Available Strengths: 75 mg 150 mg 300 mg Product Highlights: � Most affordable H2 blocker � very high demand in emerging markets � WHO-GMP, DCGI approved � Widely exported to Africa, ASEAN, Middle East � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #RanitidineTablet #ZantacGeneric #RantacGeneric #H2Blocker #GERDMedicine #PepticUlcerTablet #RanitidineManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Cleocin (Clindamycin) Capsule Lincosamide for MRSA, Anaerobes & Dental Infections Narix Pharmaceuticals Narix Pharmaceuticals manufactures Clindamycin Capsules, a lincosamide antibiotic with excellent activity against gram-positive organisms including MRSA, anaerobes, and organisms causing skin, bone, dental, and pelvic infections. Key Therapeutic Uses: � MRSA skin and soft tissue infections � Anaerobic infections � abdominal, pelvic, dental � Aspiration pneumonia and lung abscess � Bone and joint infections (osteomyelitis) � Bacterial vaginosis oral regimen Available Strengths: 150 mg 300 mg Product Highlights: � Excellent bone and tissue penetration � WHO-GMP, DCGI approved � Alu-Alu blister, bulk export ready � PCD pharma franchise available Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #ClindamycinCapsule #CleocinjGeneric #LincosamideAntibiotic #MRSAMedicine #AnaerobicInfection #DentalAntibiotic #ClindamycinManufacturer #AntibioticCapsule #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Zanaflex (Tizanidine) Tablet Central Alpha-2 Agonist Muscle Relaxant for Spasticity Narix Pharmaceuticals Narix Pharmaceuticals manufactures Tizanidine Tablets, a central alpha-2 agonist reducing spasticity by inhibiting polysynaptic reflex arcs � with shorter duration than baclofen for symptom-specific spasm control. Key Therapeutic Uses: � Spasticity in multiple sclerosis (MS) � Spinal cord injury spasticity � Muscle spasm in cervical and lumbar disorders � Low back pain with muscle spasm component � Spasticity in cerebral palsy (off-label) Available Strengths: 2 mg 4 mg 6 mg Product Highlights: � Shorter duration than baclofen � titrable spasm control � Sirdalud brand equivalent � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #TizanidineTablet #ZanflexGeneric #TizanGeneric #MuscleRelaxantTablet #SpasticityMedicine #BackPainTablet #TizanidineManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Namenda (Memantine) Tablet NMDA Antagonist for Moderate-to-Severe Alzheimer's Narix Pharmaceuticals Narix Pharmaceuticals manufactures Memantine Tablets, the only NMDA receptor antagonist approved for Alzheimer's disease � reducing glutamate excitotoxicity to slow progression, frequently combined with donepezil for additive benefit. Key Therapeutic Uses: � Moderate-to-severe Alzheimer's disease � first-line � Vascular dementia � cognitive protection � Combined with donepezil � superior vs monotherapy � OCD augmentation (off-label, growing evidence) Available Strengths: 5 mg 10 mg ER 7/14/21/28 mg Product Highlights: � Only anti-glutamate drug for Alzheimer's � Once-daily ER and twice-daily IR formulations � Donepezil combination available � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #MemantineTablet #NamendaGeneric #AdmentaGeneric #NMDAantagonist #AlzheimersMedicine #ModerateToSevereAD #MemantineManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Prilosec (Omeprazole) Capsule First PPI for GERD, Ulcers & H. pylori Eradication Narix Pharmaceuticals Narix Pharmaceuticals manufactures Omeprazole Capsules, the original and most widely prescribed proton pump inhibitor (PPI) � suppressing gastric acid by irreversibly binding H+/K+ ATPase in gastric parietal cells, used globally for GERD, peptic ulcers, and H. pylori eradication. Key Therapeutic Uses: � GERD and reflux esophagitis � first-line PPI � Duodenal and gastric ulcer treatment � H. pylori eradication (triple/quadruple therapy) � NSAID-induced ulcer prevention and treatment � Zollinger-Ellison syndrome � Stress ulcer prophylaxis in ICU Available Strengths: 10 mg 20 mg 40 mg capsules Product Highlights: � WHO essential medicine � highest global prescription volume � WHO-GMP, DCGI approved � Available as capsules, tablets, and IV formulations � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #OmeprazoleCapsule #PrilosecGeneric #OmezGeneric #ProtonPumpInhibitor #GERDMedicine #AcidRefluxTablet #OmeprazoleManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine #HPyloriEradication

Mesterolone (Proviron) API Powder Androgenic Steroid for Male Infertility & Hypogonadism Narix Pharmaceuticals Narix Pharmaceuticals supplies Mesterolone API Powder, a synthetic androgenic steroid used in pharmaceutical manufacturing of tablets for male infertility (oligospermia), androgen deficiency, and hypogonadism treatment. Technical Specifications: � CAS Number: 1424-00-6 Purity: Greater than 99% � Grade Standard: USP Form: Powder � Packaging: 1 Kg MOQ: 1 Kg Applications: Proviron tablet manufacturing, male fertility formulations, androgen deficiency treatment Storage: Sealed, cool dry storage #MesteroloneAPI #ProvironAPIManufacturer #MaleInfertilityAPI #HypogonadismAPI #PharmaceuticalAPI #WHOGMPCertified #NarixPharmaceuticals

Tyzeka (Telbivudine) Tablet L-Nucleoside Analogue for Chronic Hepatitis B Narix Pharmaceuticals Narix Pharmaceuticals supplies Telbivudine Tablets, an L-nucleoside analogue that selectively inhibits HBV DNA polymerase � with potent HBV suppression and unique benefit of improving renal function (GFR improvement) unlike other nucleos(t)ide analogues. Key Therapeutic Uses: � Chronic hepatitis B � HBeAg positive and negative � Hepatitis B with renal impairment � GFR-improving property � Pregnant HBV patients � better maternal safety profile � HBV with elevated viral load requiring potent suppression Available Strengths: 600 mg Product Highlights: � Improves renal function � unique among HBV drugs � WHO-GMP, DCGI approved � Safe in pregnancy � important for PMTCT of HBV � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #TelbivudineTablet #TyzekaGeneric #SebivoGeneric #HepatitisBTablet #RenalSafeHBV #TelbivudineManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Tetralysal (Lymecycline) Capsule Water-Soluble Tetracycline for Acne & Soft Tissue Infections Narix Pharmaceuticals Narix Pharmaceuticals manufactures Lymecycline Capsules, a water-soluble tetracycline with higher bioavailability and better absorption than tetracycline � providing anti-inflammatory and antibacterial benefits for acne vulgaris and respiratory/soft tissue infections. Key Therapeutic Uses: � Moderate-to-severe acne vulgaris � systemic antibiotic � Rosacea � anti-inflammatory tetracycline � Atypical pneumonia � Mycoplasma, Chlamydophila � Soft tissue and skin infections Available Strengths: 300 mg 408 mg Product Highlights: � Water-soluble tetracycline � higher bioavailability � Can be taken with food (unlike tetracycline) � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #LymecyclineCapsule #TetralysalGeneric #AcneTetracycline #WaterSolubleTetracycline #AcneAntibiotic #LymecyclineManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine